Skip to content
Delayed ~15 min

CXT CRANE NXT

Permanent stock page ↗

Industrials · Russell 2000

Next earnings: not announced yet

What 9 analyst firms say about CRANE NXT: their latest ratings, price targets and how far the stock is from them. How it works

57.57 USD−1.72 (−2.90%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+15.5%to the avg target 66.50 USD+8.93 USD
Buy 4 · Hold 2 · Sell 0

6 rated views · 9 analyst/firm records · 9 firms

Latest report22 Sep 2026avg report date 3 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8018
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8031

Recent analyst activity · last 90 days

Our tracked history has 5 reports on CXT from 4 analyst firms in the last 90 days (9 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdMichael P HalloranConflictConflicting reports · excluded7 Aug 202668.00 USD
Cjs SecuritiesUnnamed analystBuy11 Dec 2025—
DA DavidsonMatt SummervilleBuy18 Sep 202685.00 USD
JefferiesStephen VolkmannBuy22 Sep 202660.00 USD
Northland Capital MarketsBobby Brooks—10 Aug 202665.00 USD
OppenheimerIan ZaffinoBuy15 Apr 202665.00 USD
UBSAmit MehrotraHold7 Aug 202656.00 USD
Weiss RatingsUnnamed analyst—13 Aug 2026—
Data feed RESEARCHResearch TeamHold12 May 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:50 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.